Your browser doesn't support javascript.
loading
The circular RNome of primary breast cancer.
Smid, Marcel; Wilting, Saskia M; Uhr, Katharina; Rodríguez-González, F Germán; de Weerd, Vanja; Prager-Van der Smissen, Wendy J C; van der Vlugt-Daane, Michelle; van Galen, Anne; Nik-Zainal, Serena; Butler, Adam; Martin, Sancha; Davies, Helen R; Staaf, Johan; van de Vijver, Marc J; Richardson, Andrea L; MacGrogan, Gaëten; Salgado, Roberto; van den Eynden, Gert G G M; Purdie, Colin A; Thompson, Alastair M; Caldas, Carlos; Span, Paul N; Sweep, Fred C G J; Simpson, Peter T; Lakhani, Sunil R; Van Laere, Steven; Desmedt, Christine; Paradiso, Angelo; Eyfjord, Jorunn; Broeks, Annegien; Vincent-Salomon, Anne; Futreal, Andrew P; Knappskog, Stian; King, Tari; Viari, Alain; Børresen-Dale, Anne-Lise; Stunnenberg, Hendrik G; Stratton, Mike; Foekens, John A; Sieuwerts, Anieta M; Martens, John W M.
  • Smid M; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands.
  • Wilting SM; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands.
  • Uhr K; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands.
  • Rodríguez-González FG; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands.
  • de Weerd V; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands.
  • Prager-Van der Smissen WJC; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands.
  • van der Vlugt-Daane M; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands.
  • van Galen A; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands.
  • Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
  • Butler A; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, United Kingdom.
  • Martin S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
  • Davies HR; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
  • Staaf J; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
  • van de Vijver MJ; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.
  • Richardson AL; Department of Pathology, Academic Medical Center, 1105AZ Amsterdam, the Netherlands.
  • MacGrogan G; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
  • Salgado R; Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
  • van den Eynden GGGM; Département de Biopathologie, Institut Bergonié, CS 61283 33076 Bordeaux, France.
  • Purdie CA; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, B-1000 Brussels, Belgium.
  • Thompson AM; Department of Pathology/TCRU GZA, 2610 Antwerp, Belgium.
  • Caldas C; Department of Pathology/TCRU GZA, 2610 Antwerp, Belgium.
  • Span PN; Molecular Immunology Unit, Jules Bordet Institute, B-1000 Brussels, Belgium.
  • Sweep FCGJ; Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom.
  • Simpson PT; Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom.
  • Lakhani SR; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
  • Van Laere S; Department of Radiation Oncology, and Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands.
  • Desmedt C; Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands.
  • Paradiso A; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, 4029 Brisbane, Australia.
  • Eyfjord J; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, 4029 Brisbane, Australia.
  • Broeks A; Pathology Queensland, The Royal Brisbane and Women's Hospital, 4029 Brisbane, Australia.
  • Vincent-Salomon A; Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium.
  • Futreal AP; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, B-1000 Brussels, Belgium.
  • Knappskog S; Istituto Tumori G Paolo II, IRCCS, 70124 Bari, Italy.
  • King T; Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland.
  • Viari A; The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Børresen-Dale AL; Institut Curie, Department of Pathology and INSERM U934, 75248 Paris Cedex 05, France.
  • Stunnenberg HG; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA.
  • Stratton M; Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.
  • Foekens JA; Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway.
  • Sieuwerts AM; Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
  • Martens JWM; Synergie Lyon Cancer, Centre Léon Bérard, Lyon Cedex 08, France.
Genome Res ; 29(3): 356-366, 2019 03.
Article en En | MEDLINE | ID: mdl-30692147
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ARN / Biomarcadores de Tumor Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ARN / Biomarcadores de Tumor Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article